RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KPTI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Karyopharm Therapeutics Inc. stock price on Wednesday which ended trading at $1.48
(Updated on Mar 27, 2024)

Buy or Hold candidate since Feb 01, 2024 Gain 64.39% PDF

The Karyopharm Therapeutics Inc. stock price gained 6.47% on the last trading day (Wednesday, 27th Mar 2024), rising from $1.39 to $1.48. During the last trading day the stock fluctuated 10.22% from a day low at $1.37 to a day high of $1.51. The price has been going up and down for this period, and there has been a 4.23% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 744 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.90 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 59.05% during the next 3 months and, with a 90% probability hold a price between $1.99 and $3.35 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KPTI Signals & Forecast

The Karyopharm Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.41 and $1.36. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -10.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.35 and $1.31. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Karyopharm Therapeutics Inc. finds support just below today's level at $1.35. If this is broken, then the next support from accumulated volume will be at $1.31 and $1.30.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.140 between high and low, or 10.22%. For the last week, the stock has had daily average volatility of 6.81%.

Our recommended stop-loss: $1.39 (-6.06%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 35 days ago.)

Trading Expectations (KPTI) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Karyopharm Therapeutics Inc. to open at $1.45, and during the day (based on 14 day Average True Range), to move between $1.34 and $1.62, which gives a possible trading interval of +/-$0.142 (+/-9.59%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.51 (2.03%) than the support at $1.35 (8.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Karyopharm Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Karyopharm Therapeutics Inc. stock to perform well in the short-term.

Current score: 4.458 Buy Candidate Unchanged

Predicted Opening Price for Karyopharm Therapeutics Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$1.45 ( 1.80%) $1.48

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KPTI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.59 7.66 %
R2 1.54 4.04 %
R1 1.51 1.81 %
Current price: 1.48
Support S1 1.40 -5.42 %
S2 1.37 -7.65 %
S3 1.31 -11.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.66 12.16 %
R2 1.53 3.38 %
R1 1.51 2.03 %
Current price 1.48
Support S1 1.35 -8.78%
S2 1.31 -11.49%
S3 1.30 -12.16%

FAQ

What is the symbol for Karyopharm Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Karyopharm Therapeutics Inc. is KPTI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Karyopharm Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Karyopharm Therapeutics Inc. stock to perform well in the short-term.

How to buy Karyopharm Therapeutics Inc. Stock?
Karyopharm Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Karyopharm Therapeutics Inc. Stock.

What's the current price of Karyopharm Therapeutics Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Karyopharm Therapeutics Inc. (KPTI) share was $1.48.

What is the 52-week high and low for Karyopharm Therapeutics Inc. Stock?
The 52-week high for Karyopharm Therapeutics Inc. Stock is $4.87 and the 52-week low is $0.617.

What is the market capitalization of Karyopharm Therapeutics Inc. Stock?
As of the 2024-03-27, the market capitalization of Karyopharm Therapeutics Inc. is 170.299M.

When is the next earnings date for Karyopharm Therapeutics Inc.?
The upcoming earnings date for Karyopharm Therapeutics Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics. Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo... KPTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT